Literature DB >> 27330449

2014 Epilepsy Benchmarks: Progress and Opportunities.

Cara Long1, Brandy Fureman2, Ray Dingledine3.   

Abstract

Entities:  

Year:  2016        PMID： 27330449      PMCID： PMC4913855          DOI： 10.5698/1535-7511-16.3.179

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  2 in total

Review 1.  Anti-epileptogenic clinical trial designs in epilepsy: issues and options.

Authors:  Dieter Schmidt; Daniel Friedman; Marc A Dichter
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 2.  Candidate drug targets for prevention or modification of epilepsy.

Authors:  Nicholas H Varvel; Jianxiong Jiang; Raymond Dingledine
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-08-25       Impact factor: 13.820
  2 in total
  7 in total

1.  Imaging pathological activities of human brain tissue in organotypic culture.

Authors:  Caroline Le Duigou; Etienne Savary; Mélanie Morin-Brureau; Daniel Gomez-Dominguez; André Sobczyk; Farah Chali; Giampaolo Milior; Larissa Kraus; Jochen C Meier; Dimitri M Kullmann; Bertrand Mathon; Liset Menendez de la Prida; Georg Dorfmuller; Johan Pallud; Emmanuel Eugène; Stéphane Clemenceau; Richard Miles
Journal:  J Neurosci Methods       Date:  2018-02-07       Impact factor: 2.390

2.  Home-cage monitoring ascertains signatures of ictal and interictal behavior in mouse models of generalized seizures.

Authors:  Miranda J Jankovic; Paarth P Kapadia; Vaishnav Krishnan
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

3.  The 2021 Epilepsy Research Benchmarks-Respecting Core Principles, Reflecting Evolving Community Priorities.

Authors:  Eric D Marsh; Vicky Whittemore; Miriam Leenders; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2021-06-30       Impact factor: 7.500

4.  Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs.

Authors:  Peter J West; Kyle Thomson; Peggy Billingsley; Timothy Pruess; Carlos Rueda; Gerald W Saunders; Misty D Smith; Cameron S Metcalf; Karen S Wilcox
Journal:  Exp Neurol       Date:  2021-12-17       Impact factor: 5.620

5.  Corneal kindled C57BL/6 mice exhibit saturated dentate gyrus long-term potentiation and associated memory deficits in the absence of overt neuron loss.

Authors:  Gregory J Remigio; Jaycie L Loewen; Sage Heuston; Colin Helgeson; H Steve White; Karen S Wilcox; Peter J West
Journal:  Neurobiol Dis       Date:  2017-06-15       Impact factor: 7.046

6.  Investigating imaging network markers of cognitive dysfunction and pharmacoresistance in newly diagnosed epilepsy: a protocol for an observational cohort study in the UK.

Authors:  Christophe de Bézenac; Marta Garcia-Finana; Gus Baker; Perry Moore; Nicola Leek; Rajiv Mohanraj; Leonardo Bonilha; Mark Richardson; Anthony Guy Marson; Simon Keller
Journal:  BMJ Open       Date:  2019-10-16       Impact factor: 2.692

7.  The Benchmarks: Progress and Emerging Priorities in Epilepsy Research.

Authors:  Annapurna Poduri; Vicky Holets Whittemore
Journal:  Epilepsy Curr       Date:  2019-12-23       Impact factor: 7.500
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.